A candid case study of a failed pharma startup deal — lessons on risk, relationships, and protecting a startup’s business.
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
To advance digital health, pharmaceutical companies and start-ups should partner. There are many benefits to both from working together.
Innovating in highly regulated industries can be challenging, but it is necessary. For innovation to flourish despite legal and regulatory obstacles, we must address innovation barriers head-on.